Press Release Archive - Financial News

Financial News

04.23.2013
Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Acquisition Amortization
04.02.2013
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Fourth Quarter Earnings
01.17.2013
Forest Laboratories, Inc. Announces Health Canada Approval of BYSTOLIC for the Treatment of Hypertension
01.15.2013
Forest Laboratories, Inc. Reports Fiscal Year 2013 Third Quarter Earnings
01.02.2013
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Third Quarter Earnings
11.14.2012
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer’s Disease
10.16.2012
Forest Laboratories, Inc. Reports Fiscal Year Second Quarter 2013 GAAP Earnings Per Share of $0.08
10.01.2012
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 Second Quarter Earnings
07.17.2012
Forest Laboratories, Inc. Reports Fiscal Year First Quarter 2013 Earnings Per Share of $0.21
07.09.2012
Howard Solomon Sends Letter to Carl Icahn